Related Experiment Video
Updated: Feb 6, 2026
07:17
Single-Cell Calcium Imaging for Studying the Activation of Calcium Ion Channels
Published on: December 13, 2024
1.8K
Calcium release-activated calcium channels and pain
Yixiao Mei1, James E Barrett2, Huijuan Hu1
1Department of Anesthesiology, Rutgers New Jersey Medical School, Newark, NJ 07103, United States.
Cell Calcium
|August 11, 2018
Summary
Calcium release-activated calcium (CRAC) channels, crucial for cell signaling, are found in the nervous system and linked to chronic pain. The Orai1 CRAC channel shows promise as a new target for pain management.
Area of Science:
- Neuroscience
- Molecular Biology
- Physiology
Background:
- Calcium release-activated calcium (CRAC) channels are vital ion channels activated by intracellular calcium store depletion.
- CRAC channels are well-characterized in the immune system and implicated in various disorders.
- Emerging evidence highlights CRAC channel expression and function within the nervous system.
Purpose of the Study:
- To review the expression, distribution, and function of CRAC channels in the nervous system.
- To discuss the role of CRAC channels in neuronal and glial cells.
- To explore the involvement of CRAC channels in nociception and chronic pain.
Main Methods:
- Literature review of studies on CRAC channel expression and function in the nervous system.
- Analysis of research linking CRAC channels to pain pathways.
- Synthesis of findings on Orai1's role in pain modulation.
Main Results:
- CRAC channels are expressed in the dorsal root ganglion, spinal cord, and brain regions.
- These channels play a significant role in neurons and glial cells.
- Evidence suggests CRAC channels are involved in nociception and the development of chronic pain.
Conclusions:
- The CRAC channel Orai1 is significantly involved in pain modulation.
- Orai1 represents a potential therapeutic target for pathological pain conditions.
- Further research is needed to elucidate the physiological activation mechanisms of CRAC channels.
Related Concept Videos
01:17Antiepileptic Drugs: Calcium Channel Blockers
1.3K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.3K
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
1.8K
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.8K
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.5K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.5K
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
1.9K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.9K
01:21Skeleton and Calcium Homeostasis
6.0K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
6.0K
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
550
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
550